Clinical Trial Update: Immunoinflammatory Regulation of Esketamine in Septic Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating immunoinflammatory regulation of esketamine in septic patients. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Esketamine (esketamine)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Esketamine, Sepsis | Phase 4 | Status: RECRUITING